Stocks and Investing
Stocks and Investing
Wed, April 4, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, April 3, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
M. Auster Upgraded (UTHR) to Hold on, Apr 3rd, 2018
M. Auster of Credit Suisse, Upgraded "United Therapeutics Corporation" (UTHR) to Hold on, Apr 3rd, 2018.
M. has made no other calls on UTHR in the last 4 months.
There is 1 other peer that has a rating on UTHR. Out of the 1 peers that are also analyzing UTHR, 0 agree with M.'s Rating of Hold.
This is the rating of the analyst that currently disagrees with M.
- Geoff Meacham of "Barclays" Maintained at Sell with Decreased Target to $105 on, Thursday, February 22nd, 2018
Contributing Sources